Загрузка...
Efficacy and safety of sacubitril‐valsartan in heart failure: a meta‐analysis of randomized controlled trials
AIMS: Sacubitril‐valsartan has been shown to have superior effects over angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers in patients with heart failure (HF) and hypertension. The efficacy and safety of sacubitril‐valsartan in patients with HF are controversial. We performed...
Сохранить в:
| Опубликовано в: : | ESC Heart Fail |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7754944/ https://ncbi.nlm.nih.gov/pubmed/32977362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12974 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|